Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Wysenski Nancy Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 224 shares @ $27.88, valued at $6.2k
07/10/2023 4 Wysenski Nancy (Director) has filed a Form 4 on Alkermes plc.
Txns: Paid exercise price by delivering 1,430 shares @ $29.88, valued at $42.7k
Exercised 5,957 options to buy @ $0
07/05/2023 4 Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 187 shares @ $33.36, valued at $6.2k
06/30/2023 4 Wysenski Nancy (Director) has filed a Form 4 on Alkermes plc.
Txns: Granted 12,732 options to buy @ $31.33, valued at $398.9k
Granted 5,985 options to buy @ $0
05/18/2023 4 Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 5,000 shares @ $0
Granted 10,000 options to buy @ $37.89, valued at $378.9k
05/10/2023 4 Wysenski Nancy (Director) has filed a Form 4 on Alkermes plc.
Txns: Sold 41,250 shares @ $31.2433, valued at $1.3M
Exercised 35,000 options to buy @ $31.13, valued at $1.1M
Exercised 6,250 options to buy @ $31.13, valued at $194.6k
04/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2023 4 Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 149 shares @ $37.71, valued at $5.6k
01/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2022 4 Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 110 shares @ $51.11, valued at $5.6k
07/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/08/2022 4 Wysenski Nancy (Director) has filed a Form 4 on Alkermes plc.
Txns: Granted 5,957 options to buy @ $0
Granted 11,554 options to buy @ $31.48, valued at $363.7k
06/16/2022 4 Wysenski Nancy (Director) has filed a Form 4 on Alkermes plc.
Txns: Paid exercise price by delivering 695 shares @ $27.19, valued at $18.9k
Exercised 7,585 options to buy @ $0
05/18/2022 4 Wysenski Nancy (Director) has filed a Form 4 on Provention Bio, Inc.
Txns: Granted 33,000 options to buy @ $4.52, valued at $149.2k
05/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/01/2022 4 Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 146 shares @ $38.38, valued at $5.6k
01/04/2022 4 Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 122 shares @ $46, valued at $5.6k
12/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/04/2021 4 Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 153 shares @ $36.74, valued at $5.6k
07/08/2021 4 Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 31 shares @ $19.77, valued at $612.9
07/06/2021 3/A Wysenski Nancy (Director) has filed a Form 3/A on CYTOKINETICS INC
07/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
06/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/04/2020 4 Wysenski Nancy (Director) has filed a Form 4 on Alkermes plc.
Txns: Granted 11,509 options to buy @ $18.82, valued at $216.6k
Granted 5,578 options to buy @ $0
11/20/2020 4 Wysenski Nancy (Director) has filed a Form 4 on CYTOKINETICS INC
Txns: Granted 35,000 options to buy @ $15.99, valued at $559.7k
11/20/2020 3 Wysenski Nancy (Director) has filed a Form 3 on CYTOKINETICS INC
07/16/2020 4 Wysenski Nancy (Director) has filed a Form 4 on Provention Bio, Inc.
Txns: Granted 22,200 options to buy @ $12.62, valued at $280.2k
05/22/2020 4 Wysenski Nancy (Director) has filed a Form 4 on Alkermes plc.
Txns: Granted 12,823 options to buy @ $16.85, valued at $216.1k
Granted 6,104 options to buy @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy